ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Yukie T. Bean(Oregon Health & Science University), Allan Jensen(Danish Cancer Society), Murray D. Norris(Cancer Clinic), Yi Lu(Karolinska Institutet), Ellen L. Goode(Mayo Clinic in Arizona), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Michelle J. Henderson(New South Wales Department of Health), Peter A. Fasching(Universitätsklinikum Erlangen), Claus Høgdall(Copenhagen University Hospital), Florian Heitz(Kliniken Essen-Mitte), Robert A. Vierkant(Mayo Clinic), Anna DeFazio(The University of Sydney), M Camey(University of Hawaiʻi at Mānoa), Stuart MacGregor(The University of Queensland), Estrid Høgdall(University of Copenhagen), Ellen L. Hedditch(Cancer Institute of New South Wales), Matthew H. Law(Queensland University of Technology), Douglas A. Levine(New York University), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), Andreas du Bois(Kliniken Essen-Mitte), Amanda J. Russell(University of Minnesota), Kathryn L. Terry(Brigham and Women's Hospital), Robert Brown(Emerson College), Sián Fereday(Peter MacCallum Cancer Centre), Ignace Vergote(KU Leuven), Evelyn Despierre(KU Leuven), Daniel W. Cramer(Brigham and Women's Hospital), Joellen Shildkraut(University of Virginia), Tanja Pejović(Oregon Health & Science University), Bo Gao(Sun Yat-sen University), Michelle Haber(Cancer Clinic), Philipp Harter(Kliniken Essen-Mitte), Beth Y. Karlan(University of California, Los Angeles), Ira Schwaab(Cancer Institute of New South Wales), Galina Lurie(Cancer Prevention Institute of California), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Jenny Lester(Cedars-Sinai Medical Center), Sandrina Lambrechts(Dartmouth College), Catherine Emmanuel(Peter MacCallum Cancer Centre), Brooke L. Fridley(Children's Mercy Hospital), Pamela J. Thompson(Cancer Prevention Institute of California), Julie M. Cunningham(Cancer Research UK)
Cited by 63
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k